BioN­Tech teams up with Fo­s­un Phar­ma to test Covid-19 mR­NA vac­cine in Chi­na — and scores $50M in­vest­ment

Hav­ing qui­et­ly launched its own mR­NA vac­cine ef­forts against the nov­el coro­n­avirus to match the high­er pro­file cam­paigns of Mod­er­na and Cure­Vac, Ger­many’s BioN­Tech has …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER